TrialAmerican journal of hematology2021

Involved free light chains <10 mg/L with treatment predict better outcomes in systemic light-chain amyloidosis.

Amandeep Godara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.